Toxoplasmosis in Hemodialysis and Healthy Individuals in Shush County, Southwest of Iran

Document Type : Original Article


Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.


Introduction:Toxoplasmosis is caused by Toxoplasma gondii. Hemodialysis patients are at higher risk for the toxoplasmosis than healthy people and a rapid and definitive diagnosis is important in these individuals. Thus, the aim of the research was to investigate the toxoplasmosis in hemodialysis and healthy individuals in Shush County, southwest of Iran in 2016.
Methods: In the research of cross-sectional, 82 hemodialysis patients (the test group) and 82 healthy individuals (the control group) were randomly selected. IgG and IgM of T. gondii were measured by the ELISA method.
Results:Of 82 control group, 46 (56.1%) and 36 (43.9%) were males and females, respectively that of 82, 25 (30.48%) were positive for IgG (15 (60%) and 10 (40%) for males and females, respectively). In the test group, 46 (56.1%) and 36 (43.9%) were males and females, respectively. Of 82, 42 (51.21%) was positive for IgG (21 (50%) for both males and females). IgM of T. gondii was negative in both test and control groups. A significant difference was found between the test and control groups for IgG (P =0.007) but, no significant differences were between the gender and/or the age with IgG in both test and control groups (P >.05).
Conclusion: The results indicated that the prevalence of T. gondii was higher in hemodialysis patients than healthy persons. Since, hemodialysis patients have immunodeficiency; so, the health authorities of the city must pay more attention to control of the infection, especially in hemodialysis patients.


1. Tappeh K, Mohammadzadeh H, Khashaveh S, Rezapour B. Prevalence of intestinal parasitic infections among primary school students in Barandooz-Chay rural region of Urmia, 2007. Urmia Med J. 2010; 21(3):237-42.
2. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta trop. 2014;137:185-94.
3. Gharavi M, Rahnama N, Jahani M. Seroepidemiological survey of Toxoplasma infections of mentally retarded children. Iran J Public Health. 2005; 34(1):19-22.
4. Torda A. Toxoplasmosis: are cats really the source?. Aust Fam Physician. 2001; 30(8):743.
5. Gharavi M, Jalali S, Khademvatan S, Heydari S. Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre-and post-transplantation status. Ann Trop Med Parasitol. 2011; 105(5):367-71.
6. Soltani S, Khademvatan S, Saki J, Shahbazian H. Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran. Jundishapur J Microbiol. 2013; 6(9):1-5. doi:10.5812/jjm.7642
7. Maraghi S, Yadyad MJ, Sheikhi M, Shamakhteh F, Latifi SM. Study the anti-Toxoplasma antibodies (IgG and IgM) in hemodialysis patients of Abadan and Khoramshahr cities Southwest Iran in 2011 using ELISA. Jundishapur J Microbiol. 2013; 6(7):1-4.  doi:10.5812/jjm.7113
8. Ocak S, Duran N, Eskiocak AF, Aytac H. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey. Saudi Med J. 2005; 26(9):1378-82.  PMID:16155651
9. Saki J, Khademvatan S, Soltani S, Shahbazian H. Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods. Parasitol Res. 2013; 112(1):163-8.
10. Firouz ZE, Kaboosi H, Nasiri AF, Tabatabaie SS, Golhasani-Keshtan F, Zaboli F. A comparative serological study of toxoplasmosis in pregnant women by CLIA and ELISA methods in Chalus City Iran. Iran Red Crescent Med J. 2014;16(4):e15115.   doi:10.5812/ircmj.15115
11. House A. Psychosocial problems of patients on the renal unit and their relation to treatment outcome. J psychosom Res. 1987; 31(4):441-52.
12. Szepietowski JC, Reich A, Pacan P. Psychodermatoses in haemodialysis patients. Dermatol. 2004; 209(4):344-5.  doi:10.1159/000080865
13. Vonesh EF, Snyder J, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004; 66(6):2389-401.
14. Langhoff E, Ladefoged J. In vitro immune functions in patients with minor, moderate, and severe kidney impairment. APMIS. 1988; 96(7‐12):655-9.  doi:10.1111/j.1699-0463.1988.tb00925.x
15. Zadeh AE, Bamedi T, Etemadi S, Shahrakipour M, Saryazdipour K. Toxoplasmosis as a complication of transfusion in hemodialysis patients. Iran J Ped Hematol Oncol. 2014; 4(1):22.  PMID: 24734160
16. Rasti S, Hassanzadeh M, Soliemani A, Hooshyar H, Mousavi SGA, Nikoueinejad H, et al. Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran. Ren Fail. 2016; 38(6):970-3.
17. Rezavand B, Poornaki AM, Mokhtari KR, Mohammad A, Andalibian A, Abdi J. Identification and determination of the prevalence of Toxoplasma gondii in patients with chronic renal failure by ELISA and PCR. Asian Pac J Trop Dis. 2016; 6(5):347-9.
18. Abdul-Aziz AI, Zghair KH. Study of Epidemiology of Toxoplasmosis in Hemodialysis Patients in Baghdad Hospitals. Iraqi J Sci. 2014; 55: 1236-42.
19. Bottieau E. Tropical parasitic diseases and immunosuppression. Clin Microbiol Infect. 2014; 20(4):277.  doi:10.1111/1469-0691.12590